Company page

Cytosorbents Corporation

Cytosorbents Corporation, trading under the ticker CTSO, is a public company based in America with a market capitalization of approximately $27.5 million. The company focuses on developing innovative therapeutic solutions for critical care and other medical applications. Cytosorbents aims to improve patient outcomes through its advanced technologies.